- FILTERS Advanced
- Product Type
- Clonality
- Application
- Species / Reactivity
- Source / Host
- Conjugation
- CE / IVD
- Clone ID
- Biosite Product Line
- Supplier
- EXCLUDE FILTERS
- Clonality
- Application
- Species / Reactivity
- Conjugation
- Clone ID
- Biosite Product Line
- Supplier
Name | Art no | Species Reactivity | Application | Conjugation | Clone | Size | Price |
---|---|---|---|---|---|---|---|
155-10-054
|
virus
|
ELISA, IHC
|
HRP
|
2165
|
0.05 mg
|
||
155-10-057
|
virus
|
ELISA, IHC
|
HRP
|
2146
|
0.05 mg
|
||
155-10-063
|
virus
|
ELISA
|
HRP
|
2196
|
0.05 mg
|
||
LS-C821475-0.05
|
human, plant
|
ELISA
|
Unconjugated
|
M0418
|
0.05 mg
|
||
155-10-056
|
virus
|
ELISA, IHC
|
Biotin
|
2146
|
0.05 mg
|
||
155-10-053
|
virus
|
ELISA, IHC
|
Biotin
|
2165
|
0.05 mg
|
||
LS-C821476-0.05
|
human
|
Depletion, ELISA, IHC
|
Unconjugated
|
L55-81
|
0.05 mg
|
||
155-10-062
|
virus
|
ELISA
|
Biotin
|
2196
|
0.05 mg
|
||
LS-C821448-0.05
|
human, plant
|
ELISA, WB
|
Unconjugated
|
25
|
0.05 mg
|
||
155-10-073
|
human
|
|
Unconjugated
|
Epratuzumab
|
0.1 mg
|
||
155-10-556
|
virus
|
ELISA, Neutralization, WB
|
Unconjugated
|
B002
|
0.1 mg
|
||
155-10-559
|
virus
|
ELISA, Neutralization, WB
|
Unconjugated
|
B003
|
0.1 mg
|
||
155-10-535
|
virus
|
ELISA, WB
|
Unconjugated
|
N001
|
0.1 mg
|
||
155-10-569
|
virus
|
ELISA, Neutralization, WB
|
Biotin
|
B005
|
0.1 mg
|
||
155-10-539
|
virus
|
ELISA, WB
|
Unconjugated
|
N005
|
0.1 mg
|
||
155-10-070
|
human
|
|
Unconjugated
|
Eculizumab
|
0.1 mg
|
||
155-10-086
|
human
|
|
Unconjugated
|
Amatuximab
|
0.1 mg
|
||
155-10-092
|
human
|
|
Unconjugated
|
Omalizumab
|
0.1 mg
|
||
155-10-099
|
human
|
|
Unconjugated
|
Felvizumab
|
0.1 mg
|
||
155-10-068
|
human
|
|
Unconjugated
|
Bevacizumab
|
0.1 mg
|
||
155-10-065
|
virus
|
ELISA, IHC, WB
|
Unconjugated
|
1C7C7
|
0.1 mg
|
||
155-10-061
|
virus
|
ELISA
|
Unconjugated
|
2215
|
0.1 mg
|
||
155-10-774
|
human
|
|
Unconjugated
|
Domagrozumab
|
0.1 mg
|
||
155-10-769
|
human
|
|
Unconjugated
|
Carotuximab
|
0.1 mg
|
||
155-10-762
|
human
|
|
Unconjugated
|
Navicixizumab
|
0.1 mg
|
||
155-10-696
|
human
|
|
Unconjugated
|
Pepinemab
|
0.1 mg
|
||
155-10-632
|
human
|
|
Unconjugated
|
Sofituzumab
|
0.1 mg
|
||
155-10-651
|
human
|
|
Unconjugated
|
Bococizumab
|
0.1 mg
|
||
155-10-668
|
human
|
|
Unconjugated
|
Begelomab
|
0.1 mg
|
||
155-10-763
|
human
|
|
Unconjugated
|
Prezalumab
|
0.1 mg
|
||
155-10-799
|
human
|
|
Unconjugated
|
Rosmantuzumab
|
0.1 mg
|
||
155-10-725
|
human
|
|
Unconjugated
|
Trevogrumab
|
0.1 mg
|
||
155-10-746
|
human
|
|
Unconjugated
|
Landogrozumab
|
0.1 mg
|
||
155-10-767
|
human
|
|
Unconjugated
|
Naratuximab
|
0.1 mg
|
||
155-10-738
|
human
|
|
Unconjugated
|
Rovalpituzumab
|
0.1 mg
|
||
155-10-669
|
human
|
|
Unconjugated
|
Imalumab
|
0.1 mg
|
||
155-10-660
|
human
|
|
Unconjugated
|
Abrilumab
|
0.1 mg
|
||
155-10-655
|
human
|
|
Unconjugated
|
Coltuximab
|
0.1 mg
|
||
155-10-676
|
human
|
|
Unconjugated
|
Tafasitamab
|
0.1 mg
|
||
155-10-673
|
human
|
|
Unconjugated
|
Remtolumab
|
0.1 mg
|
||
155-10-690
|
human
|
|
Unconjugated
|
Isatuximab
|
0.1 mg
|
||
155-10-665
|
human
|
|
Unconjugated
|
Vanucizumab
|
0.1 mg
|
||
155-10-593
|
human
|
|
Unconjugated
|
Idarucizumab
|
0.1 mg
|
||
155-10-625
|
human
|
|
Unconjugated
|
Enfortumab
|
0.1 mg
|
||
155-10-674
|
human
|
|
Unconjugated
|
Obexelimab
|
0.1 mg
|
||
155-10-642
|
human
|
|
Unconjugated
|
Ralpancizumab
|
0.1 mg
|
||
155-10-195
|
human
|
|
Unconjugated
|
Fresolimumab
|
0.1 mg
|
||
155-10-192
|
human
|
|
Unconjugated
|
Tralokinumab
|
0.1 mg
|
||
155-10-244
|
human
|
|
Unconjugated
|
Gantenerumab
|
0.1 mg
|
||
155-10-252
|
human
|
|
Unconjugated
|
Tanezumab
|
0.1 mg
|